Introduction Hadron and ion beam radiotherapy treatment of cancer cells is currently the most advanced form of radiation therapy (1–3). The advantage of ion beam therapy lies in the high spatial conformity of delivered dose with tumor volume due to the low dose proximal and distal to the tumor, owing to an energy-dependent depth-dose profile, the Bragg-peak (4) (see Figure 1), sparing healthy tissue. Proton Beam Radiotherapy (PBRT) is the most common form of hadron therapy.